An AllTrials project

NCT06463457: An ongoing trial by Atish Choudhury, MD

This trial is ongoing. It must report results 4 years, 3 months from now.

Full data

Full entry on ClinicalTrials.gov NCT06463457
Title Comeback From Long coursE ADT With RElugolix and Darolutamide in Hormone-sensitive Prostate Cancer (CLEARED)
Results Status Ongoing
ACT or pACT? This is what FDAAA officially calls an "Applicable Clinical Trial"
Start date Dec. 13, 2024
Completion date Nov. 30, 2028
Required reporting date Nov. 30, 2029, midnight
Actual reporting date None
Date last checked at ClinicalTrials.gov Aug. 12, 2025
Days late None